Professor, Hematology ,Mayo Clinic
Location: United States
S. Vincent Rajkumar, M.D., is engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. Dr. Rajkumar served as the principal investigator on several clinical trials for the treatment of myeloma, including the pivotal trials that led to the regulatory approval of thalidomide for the treatment of the disease in the United States.
Focus areas
Significance to patient care
The research being conducted by Dr. Rajkumar will lead to better treatments and outcomes for patients with myeloma and other hematologic malignancies.
No Grants Mentioned !!